22 completed, 3 terminated, 1 unknown. 26 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 26 | Completed 22, Terminated 3, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Opportunistic Infections: new trials by email Literature Review of Opportunistic Infections trials Research Report on Opportunistic Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cryptococcal Antigen Screening Plus Sertraline Sertraline, Placebo Oral Tablet, Fluconazole - Cryptococcosis, Cryptococcal Infections | Phase 3 | Terminated | University of Minnesota | 22 | 2017-11-15 | 2020-06-09 |
| CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT CD45RA-depleted peripheral blood mononuclear cells - Leukemia, Lymphoma | Phase 2 / Phase 3 | Completed | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 150 | 2016-10-01 | 2023-03-16 |
| A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients Early versus intermediate versus late initiation of ART - HIV Infections, Tuberculosis | Phase 3 | Completed | Centre for the AIDS Programme of Research in South Africa | 642 | 2005-06-01 | 2011-03-24 |
| Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation Everolimus, Mycophenolatmofetil - Lung Transplantation | Phase 3 | Completed | Hannover Medical School | 190 | 2005-03-01 | 2011-12-08 |
| Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients Nitazoxanide - Cryptosporidiosis, HIV Infections | Phase 3 | Terminated | Romark Laboratories L.C. | 30 | 2000-02-01 | 2005-06-24 |
| Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients Posaconazole, Fluconazole - Candidiasis, Oral, HIV Infections | Phase 3 | Completed | Schering-Plough | 300 | 1998-08-01 | 2005-06-24 |
| A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis Albendazole - Protozoan Infections, HIV Infections | Phase 3 | Completed | SmithKline Beecham | 2005-06-24 | ||
| Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care Lamivudine/Zidovudine, Nelfinavir mesylate, Efavirenz - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 250 | 2011-03-02 | |
| Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Trimetrexate glucuronate, Sulfamethoxazole-Trimethoprim, Leucovorin calcium - Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 302 | 2021-11-04 | |
| A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis Ganciclovir - Cytomegalovirus Retinitis, HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-09-30 | ||
| A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3 Aldesleukin - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 460 | 2021-10-29 | |
| A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS Pentamidine isethionate, Sulfamethoxazole-Trimethoprim - Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 240 | 2021-11-03 | |
| A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002 Zidovudine, Zalcitabine - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 120 | 2021-11-03 | |
| A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients Pentamidine isethionate, Sulfamethoxazole-Trimethoprim, Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 600 | 2021-11-04 | |
| A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine Globulin, Immune, Zidovudine - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 250 | 2021-11-03 | |
| Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection Valganciclovir - Cytomegalovirus Retinitis, HIV Infections | Phase 3 | Unknown | Hoffmann-La Roche | 500 | 2005-06-24 | |
| A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT) Pentamidine isethionate, Pyrimethamine, Sulfamethoxazole/Trimethoprim - Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 322 | 2021-11-03 | |
| A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma Zidovudine - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 240 | 2021-11-04 | |
| An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies Trimetrexate glucuronate, Leucovorin calcium - Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-10-29 | ||
| Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients IM862 - Sarcoma, Kaposi, HIV Infections | Phase 3 | Completed | Cytran | 200 | 2005-06-24 |
Showing 20 of 26. Sign in to see all of them.
AIDS-Related Opportunistic Infections (23) · HIV Infections (23) · Acquired Immunodeficiency Syndrome (15) · Pneumonia, Pneumocystis (9) · Cytomegalovirus Retinitis (3) · AIDS-Related Complex (2) · Cryptococcosis (2) · Cytomegalovirus Infections (2) · Multiple Acyl Coenzyme A Dehydrogenase Deficiency (2) · Respiratory Aspiration (2) · Retinitis (2) · Sarcoma, Kaposi (2) · Tuberculosis (2) · Adolescent Behavior (1)
Infections (26) · Immune System Diseases (25) · Blood-Borne Infections (24) · Communicable Diseases (24) · Immunologic Deficiency Syndromes (24) · Lentivirus Infections (24) · RNA Virus Infections (24) · Retroviridae Infections (24) · Virus Diseases (24) · Genital Diseases (23) · Sexually Transmitted Diseases (23) · Sexually Transmitted Diseases, Viral (23) · Urogenital Diseases (23) · Bacterial Infections and Mycoses (15)
Zidovudine (7) · Trimethoprim, Sulfamethoxazole Drug Combination (6) · Pentamidine (5) · Leucovorin (4) · trimetrexate glucuronate (4) · Fluconazole (3) · Ganciclovir (2) · Albendazole (1) · Amphotericin B (1) · Dapsone (1) · Ethambutol (1) · Everolimus (1) · Immunoglobulins (1) · Isoniazid (1) · Lamivudine (1)
National Institute of Allergy and Infectious Diseases (NIAID) (15) · Schering-Plough (2) · Centre for the AIDS Programme of Research in South Africa (1) · Cytran (1) · Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1) · Hannover Medical School (1) · Hoffmann-La Roche (1) · Pfizer (1) · Romark Laboratories L.C. (1) · SmithKline Beecham (1) · University of Minnesota (1)
United States (22) · Puerto Rico (2) · Australia (1) · Barbados (1) · Belgium (1) · Canada (1) · Germany (1) · Russia (1) · South Africa (1) · Tanzania (1) · Uganda (1)
Feinberg J (2) · Fischl M (2) · Sattler FR (2) · Ariela Noy (1) · Armstrong D (1) · B Montgomery (1) · David Scadden (1) · Denis Jones (1) · Diane Havlir (1) · Dismukes W (1) · Donald I. Abrams (1) · El-Sadr W (1) · Elizabeth K Nalintya, MBChB MPH (1) · Hardy WD (1) · Holzman R (1)
PMID 20181971, PMID 22010915, PMID 22944873, PMID 32415846
U01AI125003 (1)